Matthew P. Frosch, M.D.,Ph.D.
This page shows the publications co-authored by Matthew Frosch and Teresa Gomez-Isla.
The Challenge of Defining Alzheimer Disease Based on Biomarkers in the Absence of Symptoms. JAMA Neurol. 2019 Jul 15.
Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3ß) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation. iScience. 2021 Feb 19; 24(2):102058.
Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun. 2019 03 11; 7(1):37.
Distinct cytokine profiles in human brains resilient to Alzheimer's pathology. Neurobiol Dis. 2019 01; 121:327-337.
Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease. Neurology. 2019 07 30; 93(5):e476-e484.
Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue. Sci Rep. 2016 09 15; 6:33079.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.